Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

UNCOVERED: 56 - The Untold Story

Diabetes Drugs Show Potential In Reducing Colon Cancer Risk

Groundbreaking study suggests type 2 diabetes medications may also ward off other obesity-related cancers

Zenger · Dec 8, 2023

Government inaction on obesity is harming our health

Letter: It’s easy to blame individuals, but real change can only happen if industry and the government take responsibility, says Colette Marshall of Diabetes UK. Plus a letter from Michael Fuller

The Guardian - UK · Dec 7, 2023

David Gandy on modelling, influencers and obesity in the UK: ‘I wasn’t born with this body’

The male supermodel talks to Helen Coffey about body image, how he lost his ‘puppy fat’, his new ‘influencer’ rivals and protecting his daughters from the evils of social media in the age of the internet

The Independent UK · Dec 7, 2023

From analysis to the latest developments in health,
read the most diverse news in one place.

What are the rules around fast-food takeaways and London schools?

In London, a ban on fast-food takeaways opening within 400 metres of schools was put in place in 2017

Evening Standard · Dec 6, 2023

Health: Research shows diet has a significant impact on risk of Alzheimer's disease

Alzheimer's disease rates rise in these countries as they make the nutrition transition to the Western diet. Read further on Dynamite News:

Dynamite News · Dec 6, 2023

Which Weight Loss Drug Is Best And Safest? Here’s What Sets Them Apart

Earlier this month, the FDA approved Eli Lilly's Zepbound, a drug similar to its diabetes drug Mounjaro but specifically advertised for weight loss.

Inverse · Dec 6, 2023

Cost of people being overweight in UK now £98bn, study finds

Estimate includes £63bn cost to people affected, £19bn cost to NHS and £15bn cost to society

The Guardian - UK · Dec 4, 2023

Read news from The Economist, FT, and more,
with one subscription

Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives

Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity.

International Business Times · Dec 4, 2023

Pfizer nixes more study of twice-daily obesity pill treatment that made many patients nauseous

Pfizer shares sank Friday when the drugmaker announced that it was abandoning a twice-daily obesity treatment after more than half the patients in a clinical trial stopped taking it

The Independent UK · Dec 1, 2023

Eli Lilly’s CFO explains why the company’s newest weight-loss drug Zepbound will cost 20% less than the current options

Zepbound is expected to be available in the U.S. by the end of the year.

Fortune · Nov 29, 2023

Overweight Teens Face Higher Cancer Risk, Study Shows

Obesity in adolescence linked to up to 17 different cancers, raising concerns about long-term health consequences.

Zenger · Nov 28, 2023

Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs

Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.

Fortune · Nov 27, 2023

Ultra-Processed Food-Cancer Link: Study Says Higher Risk Not Just Due To Obesity

The study has found that eating 10% more ultra-processed food raises the risk of head and neck cancer by 23% and the risk of esophageal adenocarcinoma by 24%.

Medical Daily · Nov 22, 2023

No more Thanksgiving 'food orgy'? New obesity medications change how users think of holiday meals

Holiday meals may be changing for millions of Americans struggling with obesity and taking a new generation of weight-loss drugs

The Independent UK · Nov 20, 2023

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK · Nov 18, 2023

Revealed: obesity jab maker discussed targeting benefit claimants with UK government

Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection

Barchart · Nov 17, 2023

Will Weight Loss Drugs be the Next Big Thing?

Several pharmaceutical companies are racing to develop obesity drugs and tap into a surge in consumer demand for the extremely profitable drugs. Sales of Eli Lilly’s (LLY ) diabetes drug Mounjaro, just approved by the U.S. Food and Drug Administration (FDA) for obesity in the U.S., hit $1.41 billion in...

Evening Standard · Nov 16, 2023

'As bad as 15 cigarettes a day': WHO declares loneliness a global health concern

The effects of loneliness can be greater than obesity and smoking

LiveScience · Nov 15, 2023

Here's what happens when cats get too fat (it involves acidic poop)

Obesity is wreaking havoc on cats' digestive systems, causing "significant changes" in their gut microbial compositions and giving them highly acidic poop.

Get all your
news in one place.

100's of premium titles.
One news app.

The Conversation · Nov 15, 2023

Mounjaro has been authorised for weight loss in the UK – here's how it compares to Wegovy

The type 2 diabetes drug tirzepatide (better known by its brand name Mounjaro) has recently been authorised by the UK’s medicines regulation authority for use in weight loss and weight management. The decision was made on the same day the US Food and Drug Administration (FDA) approved a version of…

The Hindu · Nov 14, 2023

Initiative launched to assist college students in Chennai stay healthy and in shape

M.V. Diabetes & M. Viswanathan Diabetes Research Centre launched Chennai Slim & Fit 2.0 to educate college students on healthy lifestyle & prevent obesity. 6,000 school students were followed in 2007, with findings published in 2013. Nina Reddy, Joint MD of Savera Hotel, urged people to look after themselves &…

The Conversation · Nov 13, 2023

Insecure renting ages you faster than owning a home, unemployment or obesity. Better housing policy can change this

People’s experiences of private rental housing are linked to faster biological ageing, our recent research finds.

The Independent UK · Nov 11, 2023

Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds

A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients

The Hindu · Nov 11, 2023

ICMR-NIN scientists find alarming obesity levels in Telangana and Andhra Pradesh

ICMR-NIN study finds alarming obesity rates in Hyderabad & Telugu States; 47.7% urban adults in Telangana & 46.7% rural adults in AP obese. Over 11% urban & 6% rural adults suffer from hypertension; 5% in both regions have diabetes. Adults aged 40-59 & those engaged in clerical/skilled/semi-skilled occupations have higher…

The Independent UK · Nov 9, 2023

FDA approves new weight loss drug

Federal regulators say a new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug

The Guardian - UK · Nov 9, 2023

AstraZeneca makes big push into weight-loss market with obesity pill deal

UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill

1 … 55 56 57 58

Coverage From

People

Lars Fruergaard Jørgensen

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

US Food and Drug Administration

Eli Lilly and Company

63 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.